Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

Keyphrases

• EGFR mutation 100%
• Non-small Cell Lung Cancer Patients 100%
• African American Ancestry 100%
• Exon 20 75%
• Epidermal Growth Factor Receptor Inhibitors (EGFRI) 75%
• Non-small Cell Lung Cancer (NSCLC) 50%
• Erlotinib 50%
• Rare mutation 50%
• PF-00299804 50%
• Kinase Activity 25%
• Patient Demographics 25%
• Deletion mutation 25%
• Point mutation 25%
• African American 25%
• Tyrosine Kinase 25%
• Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI) 25%
• Predictive Marker 25%
• Irreversible Inhibitor 25%
• Exon 19 25%
• L858R 25%
• T790M 25%
• Uncommon mutation 25%
• Exon 20 Insertion mutation 25%

Biochemistry, Genetics and Molecular Biology

• Epidermal Growth Factor Receptor 100%
• Exon 62%
• Erlotinib 25%
• Phosphotransferase 12%
• Kinase 12%
• Point Mutation 12%
• Receptor Tyrosine Kinase 12%
• Tyrosine Kinase 12%
• Receptor Tyrosine Kinase Inhibitors 12%

Neuroscience

• Epidermal Growth Factor Receptor 100%
• Exon 62%
• Erlotinib 25%
• Kinase 12%
• Point Mutation 12%
• Receptor Tyrosine Kinase 12%
• Tyrosine Kinase 12%
• Receptor Tyrosine Kinase Inhibitors 12%